Search
for
Sort by
Research 31–60 of 1000+
- Levels of sex steroids in lung tissues of patients with non‑small cell lung cancer after COVID‑19 of different severity
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Gefitinib-induced hair alterations: Figure 1
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Characters of KRT80 and its roles in neoplasms diseases
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Review of Drug Repositioning in Cancer Therapeutics
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Gefitinib: an adverse effects profile
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- “PRIDE” Complex
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- Erlotinib induced acneiform eruption: A case report
- Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines
- Hair Growth After Gefitinib Treatment
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.